Hodgkin's Disease Clinical Trials Hodgkin's Disease RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

First-in-Human (FIH) Trial of 1A46 in Subjects With Advanced CD20 and/or CD19 Positive B-cell Hematologic Malignancies
Conditions:   Non-Hodgkin's Lymphoma (Disorder);   Acute Lymphoid Leukemia, Disease (Disorder) Intervention:   Drug: 1A46 Injection Sponsor:   Chimagen Biosciences, Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2022 Category: Research Source Type: clinical trials